Select Page
Dani Brunner, Ph.D.

Dani Brunner, Ph.D.

Dr. Brunner received her PhD at Cambridge University (UK), and post-doctoral training at Columbia University (USA). She joined PsychoGenics in 1999 where she developed preclinical tests for cognition, neurodegeneration, autism, between others. She conceived the...
Mark Varney, Ph.D.

Mark Varney, Ph.D.

Dr. Varney received his Ph.D. and post-doctoral training in Pharmacology from Oxford University, UK. He is Chief Scientific Officer of PsychoGenics, a preclinical CNS service company engaged in psychiatric drug discovery. Dr. Varney has more than 30 years of...
Emer Leahy, Ph.D.

Emer Leahy, Ph.D.

Dr. Emer Leahy received her Ph.D. in Neuropharmacology from University College Dublin, Ireland, and her MBA from Columbia University. She is CEO of PsychoGenics Inc., a profitable preclinical CNS service company, and CEO of PGI Drug Discovery LLC, a company engaged in...